Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EXACT Therapeutics AS ( (DE:56F) ) has shared an announcement.
EXACT Therapeutics has released its 2024 Annual Report, highlighting its ongoing efforts in precision medicine through Acoustic Cluster Therapy (ACT®). This approach aims to revolutionize targeted drug delivery in oncology and other medical fields, potentially impacting the company’s market position and offering new opportunities for stakeholders.
More about EXACT Therapeutics AS
EXACT Therapeutics is a clinical-stage precision medicine company focused on using ultrasound and microbubbles for targeted drug delivery in oncology. Their Acoustic Cluster Therapy (ACT®) is designed to enhance the delivery of therapeutic agents across various medical conditions, including brain diseases.
YTD Price Performance: -27.04%
Technical Sentiment Signal: Strong Buy
Current Market Cap: €15.8M
For an in-depth examination of 56F stock, go to TipRanks’ Stock Analysis page.